WO2011056037A3 - 비목나무 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물 - Google Patents

비목나무 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물 Download PDF

Info

Publication number
WO2011056037A3
WO2011056037A3 PCT/KR2010/007854 KR2010007854W WO2011056037A3 WO 2011056037 A3 WO2011056037 A3 WO 2011056037A3 KR 2010007854 W KR2010007854 W KR 2010007854W WO 2011056037 A3 WO2011056037 A3 WO 2011056037A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
fractions
pharmaceutical composition
active ingredients
composition containing
Prior art date
Application number
PCT/KR2010/007854
Other languages
English (en)
French (fr)
Other versions
WO2011056037A9 (ko
WO2011056037A2 (ko
Inventor
김기옥
진영준
고려경
최호민
강민철
한종헌
고광효
Original Assignee
재단법인 제주테크노파크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 제주테크노파크 filed Critical 재단법인 제주테크노파크
Priority claimed from KR1020100110687A external-priority patent/KR101291342B1/ko
Publication of WO2011056037A2 publication Critical patent/WO2011056037A2/ko
Publication of WO2011056037A9 publication Critical patent/WO2011056037A9/ko
Publication of WO2011056037A3 publication Critical patent/WO2011056037A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

본 발명은, 비목나무(Lindera erythrocarpa) 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물에 관한 것으로, 본 발명의 조성물은 PPAR-γ 길항제로서 암, 동맥경화, 류마티스 관절염, 다발성경화증, 알츠하이머 또는 비만의 예방 또는 치료에 유용하게 사용될 수 있다.
PCT/KR2010/007854 2009-11-06 2010-11-08 비목나무 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물 WO2011056037A2 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20090107141 2009-11-06
KR10-2009-0107141 2009-11-06
KR10-2010-0110687 2010-11-08
KR1020100110687A KR101291342B1 (ko) 2009-11-06 2010-11-08 비목나무 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물

Publications (3)

Publication Number Publication Date
WO2011056037A2 WO2011056037A2 (ko) 2011-05-12
WO2011056037A9 WO2011056037A9 (ko) 2011-07-28
WO2011056037A3 true WO2011056037A3 (ko) 2011-11-03

Family

ID=43970584

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/007854 WO2011056037A2 (ko) 2009-11-06 2010-11-08 비목나무 추출물, 이의 분획물, 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 약학적 조성물

Country Status (1)

Country Link
WO (1) WO2011056037A2 (ko)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060104555A (ko) * 2005-03-30 2006-10-09 한국생명공학연구원 사이클로펜타디온 유도체를 포함하는 항암 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060104555A (ko) * 2005-03-30 2006-10-09 한국생명공학연구원 사이클로펜타디온 유도체를 포함하는 항암 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHENG-YANG, W. ET AL., PHYTOTHERAPY RES., vol. 22, 2008, pages 213 - 216 *

Also Published As

Publication number Publication date
WO2011056037A9 (ko) 2011-07-28
WO2011056037A2 (ko) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2012080727A3 (en) Casein kinase 1delta (ck1delta) inhibitors
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
WO2009153496A3 (fr) Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies
IL193762A (en) The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs
WO2008002621A3 (en) Benzyl-substituted quinolone m1 receptor positive allosteric modulators
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2008017867A3 (en) Antiretroviral solid oral composition with at least one water insoluble polymer
WO2008007244A3 (en) Composition for improving eye health
EP2268647A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE IDENTIFICATION AND TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
WO2008054808A3 (en) Elvucitabine pharmaceutical compositions
PL1845957T3 (pl) Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben
WO2013148686A3 (en) Stable igg4 binding agent formulations
WO2010058926A3 (ko) 생강 추출물 또는 쇼가올을 포함하는 약학 조성물
RS20060662A (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
MX2015001917A (es) Composiciones farmaceuticas de memantina.
TW200734338A (en) 6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
MA32635B1 (fr) Produit medicamenteux et traitement associe
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
EP2315589A4 (en) PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST
EP2323656A4 (en) PHARMACEUTICAL PRODUCT USING A MUSCARIN RECEPTOR ANTAGONIST AND A BETA-2 ADRENOZEPTORAGONIST
WO2008116737A3 (de) Kapseln enthaltend pflanzenzubereitungen
MX2007010322A (es) Extractos de planta y metodos y usos de los mismos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10828572

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10828572

Country of ref document: EP

Kind code of ref document: A2